Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2016; 11(01): 67
DOI: 10.4103/1793-5482.165795
LETTER TO EDITOR

Idarucizumab: A novel antidote for reversal of dabigatran

Abdul Rehman
Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi 74800, Sindh
,
Muhammad Awais
Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi 74800, Sindh
,
Noor Baloch
Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi 74800, Sindh
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
20 September 2022

© 2016. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India